Friday, January 17, 2014

Making sense of personal financial position using ratios

Every market savvy person is aware of the importance of technical and fundamental analysis to evaluate a company. Graphs, charts and ratios form the crux of this analysis. Financial ratios are an integral part of the financial statement of a company and it helps in comparing companies between different time periods, among companies and industries too. All these help investors in making the right investment decisions.

Similarly, if a person wants to evaluate his personal financial position based on his financial statements considering the cash flow or his net worth or whether he is over-borrowed or whether he has enough liquidity, he can gauge his position on the basis of basic financial ratios.

The components involved in reaching the appropriate ratio have been discussed below in detail.

Unlike company ratio analysis, personal financial ratio is quite simple. There are six ratios in all which help individuals to evaluate their financial position.

Basic Liquidity Ratio:

This ratio indicates an individual's ability to meet his or her monthly expenses in case of an emergency or a catastrophe.

Basic Liquidity Ratio = Cash (near cash)/Monthly Expenses

Cash (near cash) includes all liquid assets like savings a/c, Fixed Deposit, cash in hand and Liquid Funds.

Monthly Expenses include mandatory fixed and variable expenses. An average of 12 months is taken into consideration while calculating mandatory variable expense and the expenditure tends to vary every month. It does not include voluntary expenses like those on entertainment, vacation or those that can be avoided, if needed.

Liquidity Ratio:

This ratio helps a person to know his financial liquidity. Maintaining a certain level of liquidity is essential to ward off any unforeseen financial hardships. Property can be considered as a good investment avenue but lack of liquidity is its biggest drawback and while equity is risky, its biggest advantage is liquidity.

Liquidity Ratio = Liquid Assets/ Net Worth

Liquid Assets include all cash (near cash assets), equities, Equity Mutual Funds (not Equity Linked Savings Schemes as they have three years' lock-in period), Debt Funds (which include Short Term, Gilt Funds, Monthly Income Plans and other such funds except Closed-Ended Funds) and other assets which can be redeemed within three to four working days.
Net Worth is the amount left after deducting total liabilities from total assets.

The ideal liquidity ratio is 15%. At least 15% of one's portfolio should have assets, which can be redeemed almost immediately in case of an emergency. Anything less is not healthy.

Savings Ratio:

This ratio indicates the amount an individual sets aside as savings for his future goals.

Savings Ratio = Savings/ Gross Income

Savings include any form of savings like Fixed Deposits, Liquid Funds, Mutual Funds, Equities, Debt, Bonds, PPF, Post Office Small Saving Schemes and others where the individual saves on a regular basis.

Gross Income includes income earned through business, profession or in the form of salary, bonus, EPF contribution, interest, dividend, rent/royalty and any other form of income.

The ideal savings ratio is at least 10%. At least 10% of a person's gross income should go towards savings. Anything less might not be quite what one might want it to be.

Debt to Asset Ratio:

This ratio helps a person to understand whether he is over borrowed or is in a comfortable position, i.e., if he faces any solvency problems. This ratio should always be used when one is planning to take a new loan. If an individual is over borrowed, it is best to avoid getting into something new. Instead the person should wait until he has finished paying off his previous loan amount.

Debt to Asset Ratio = Total Liabilities/ Total Assets

Total Liabilities are all liabilities like personal loan, home loan, and car loan, any credit card outstanding, amount taken from private money lenders and any other form of loan.

Total Assets include all assets that a person has like investments, cash (near cash), home, car, jewellery and other assets.
The ideal debt to asset ratio is maximum 50%. The maximum debt any individual can take should not exceed 50% of his total assets.

Total Assets include all assets that a person has like investments, cash (near cash), home, car, jewellery and other assets.

The ideal debt to asset ratio is maximum 50%. The maximum debt any individual can take should not exceed 50% of his total assets.

Source: Nirmal Bang's Beyond Market

Yes, They Do: Low Interest Rates Do Make Stocks Cheap

Introduction: Pessimism Is for Losers

I'm inspired to write this article because I am so frustrated by the plethora of all the so-called expert market prognosticators that continuously bombard the public with negative forecasts. I consider this to be both erroneous and irrational. When the markets are doing well, we are immediately inundated with articles talking about how the market has surely topped and a big drop is imminent. When markets are doing poorly, we are flooded with numerous forecasts of just how bad it's going to be. The real truth of the matter is that nobody really knows. Not the Federal Reserve, nor any of the so-called experts who are more than willing to provide us with their forecasts of doom and gloom. Pessimism is pervasive, but optimism is, in fact, more accurate and rational in my opinion.

The best investing minds that I've come across, which are also the ones with the best long-term track records, universally agree that timing markets, or forecasting the economy or interest rates, etc., are exercises in futility. The great investor Bernard Baruch put it quite succinctly when he said:

"Don't try to buy at the bottom and sell at the top. It can't be done except by liars." Bernard Baruch

Or you could look to the sage advice from Peter Lynch that he offered in Chapter 2 of "Beating The Street," his best-selling book, which I highly recommend to anyone with money invested. Chapter 2 is titled: The Weekend Worrier. In this chapter Peter talks about the same issues that I'm complaining about in this article. The Weekend Worrier, as Peter calls them, always have many draconian reasons why they believe it's not a good time to invest in stocks or why the economy is bad and getting worse. But Peter makes a very strong point with the first two sentences of Chapter 2:

"The key to making money in stocks is not to get scared out of them. This cannot be over emphasized."

And later in the book Peter provides us with Peter Principle num! ber 19 where he says:

"Unless you are a short-seller or a poet looking for a wealthy spouse, it never pays to be pessimistic."

And finally, I would like to share two of his 25 Golden Rules of Investing (he actually gives us 26), numbers 18 and 19:

"Golden rule number 18- there is always something to worry about. Avoid weekend thinking and ignore the latest dire predictions of the newscasters. Sell a stock because the company's fundamentals deteriorate, not because the sky is falling."

"Golden rule number 19-nobody can predict interest rates, the future direction of the economy, or the stock market. Dismiss all such forecasts and concentrate on what's actually happening to the companies in which you've invested."

My goal with this introduction was to establish a foundation that supports optimism over pessimism. Secondarily, my objective was to point out that forecasting the economy, markets, interest rates or any other macro event is both impossible and an exercise in futility. However, it never ceases to amaze me how so many people continue to incessantly promulgate headline after headline and article after article positing their negative forecasts about the economy, the stock market, interest rates, etc. No matter how often they are proven wrong, and they usually are, they remain a persistent and shameless group.

Recently there has been a spate of articles debating whether or not stocks are cheap relative to things like interest rates or forward PE ratios. These articles really get my blood boiling because they tend to be full of forecasts about the very things which I have suggested cannot be forecast. Therefore, I find that their cases are full of opinion, but usually very light on facts. But perhaps most of all, they state their cases with an arrogance and conviction that I find too incredulous to tolerate. Therefore, my goal is to counter these articles based more on fact than opinion,and most importantly of all, on real numbers rather than ! statistic! al inferences.

Stocks Are Cheap Relative to Earnings (Past Present and Future)

Before I go on, I want to be clear, and consistent with what I've already written, by stating that I do not believe in predicting economies or stock markets in general. Instead, I believe in analyzing and investing in specific (individual) well-run companies at sensible or attractive valuations. However, if I feel compelled to talk about the markets in general, it is usually because I was incited by the types of articles I've been referring to throughout this piece. Moreover, I try to focus on the actual facts as they currently exist. Consequently, if there is any forecasting involved, it needs to be based on a short time period and upon a reasonable range of probabilities given what we do already know.

The following F.A.S.T. Graphs™ reviews the S&P 500 Index since the beginning of calendar year 1994. The orange line on this graph plots earnings-per-share at a PE ratio (earnings multiple) of 15. To be clear, as you look at this graph recognize that if the stock price (black line) is above the orange line, then the PE ratio is over 15, if the stock price is below the orange line, then the PE is less than 15, and of course if the price is touching the orange line, then the PE ratio of the S&P 500 is precisely 15. The same can be said about the historically normal price earnings ratio (blue line), however, this line is a calculated PE ratio of 19.3.

With the exception of the last earnings plot, the orange line is based on actual reported earnings (what we do already know) , and therefore, is a factual portrayal of how "Mr. Market" has been valuing the S&P 500 Index since 1994. To repeat, when the price is above the orange line the S&P 500 is overvalued, when the price is touching the orange line the S&P 500 is fairly valued, and when the price (black line) is below the orange line, as it is now, the S&P 500 is undervalued. Statistically speaking, which is a language I hate to speak in, a ! PE ratio ! of 15 is the long-term historical average PE ratio for the S&P 500. Once again, statistically speaking, a PE ratio of 20 is the historical norm over the past 20 years (note that the blue line on the graph is drawn using a calculated PE of 19.3 over the past 19 years, which is obviously very close to the 20-year average of 20).

However, even though these ratios are statistically (mathematically) portrayed, a closer scrutiny of the graph can show how statistics can be misleading. Instead of relying on a mere numerical statistical calculation, the reviewer can clearly see how the market has actually valued the S&P 500 since 1994. More importantly, by carefully studying the graph we can see a vivid and clear picture of when the S&P 500 was overvalued, fairly valued or undervalued. Therefore, based on actual 2011 earnings and Standard & Poor's Corp.'s own forecast for 2012 earnings, we see a clear depiction of the S&P 500's current valuation. Since the price is below the orange line, it is clear that current PE ratio of 13.9 on the S&P 500 indicates modest undervaluation at this time. I believe this is fact not fantasy, certainly the historical part is.

[ Enlarge Image ]

With this next graph, I plot the yield of the 10-year Treasury note (the burgundy shaded area) with the actual S&P 500 PE ratios since 1994 (dark blue line). There are two very interesting phenomenon that this graphic reveals, one I would consider normal, and the other aberrant. The normal phenomenon runs from approximately 1994 to 2002. Here we find an expected correlation between interest rates and stock values. As interest rates are falling (the yellow arrow) we see a logical increase in the PE ratio of the S&P 500 (blue line). This is logical, because as interest rates on Treasury Notes move lower, they simultaneously become less competitive with stock returns, and therefore, stock valuations increase as demand for! stocks l! ogically increases.

However, from 2002 to current time we see a conflicting relationship between interest rates and stock prices. In this case, as interest rates continued to decline, stock valuations (PEs) followed suit and declined as well. In theory, this should not happen. Because with interest rates so low, as a practical matter bonds become less competitive to stocks, but even worse, today bonds don't even offer any real return. This is especially true when you compare blue-chip dividend yields available from stalwarts such as PepsiCo (PEP), Proctor & Gamble (PG), and Johnson & Johnson (JNJ), etc., to interest rates. For the first time since I can remember, these companies are offering higher dividend yields than not only the 10-year Treasury but the 30-year as well.

Therefore, interest rates are clearly very low, which is another way of saying bond prices are excessively high. Conversely, dividend yields are significantly higher than normal, which is a straightforward and simple indicator that blue-chip dividend paying stocks at least, are currently inexpensive. Typically, bonds are attractive because and when they provide a significantly higher yield, but no growth, as compared to a stock. Therefore, when you can buy stocks with higher yields than bonds, it should be clear to anyone with any common sense that stocks are cheap and bonds are expensive.

[ Enlarge Image ]

Many authors of financial articles, and other pundits are very fond of reporting all types of statistical, what I like to call innuendo, that doesn't hold up under real world scrutiny. So maybe it's not true that statistics don't lie, and thus maybe both statistics and statisticians are darn liars. Perhaps unintentionally, but when examined against the truth, their hypotheses are more often than not proven false. Nevertheless, there is a large cadre of people that are willing to bet their portfolios! , and con! sequently their financial futures on what these authors present and promote.

The following graphic shows the actual historical record of 10-year Treasury Bond yields since 1890. Therefore, I let the reader decide for themselves whether or not interest rates are currently at aberrantly low levels or not.

[ Enlarge Image ]

Specifically, Some Stocks are Cheap and Some Are Very Expensive

As I've stated more than once for this article, I believe in dealing with specifics rather than generalities. Therefore, I offer two specific examples of well-known companies where one is cheap, while the other is expensive. The following are two examples of individual companies that are being priced by the exact same stock market. I ask that the reader please recognize that I am not writing about either of these specific examples. Instead, I am simply using them to illustrate that general statements about stocks can be very misleading.

Oracle Corp. (ORCL)

The orange line on the following historical earnings and price correlated graph of Oracle Corp. (ORCL) shows that this consistent and fast growing technology company is clearly trading below its intrinsic value (the orange line). Even though this company has grown earnings almost 3 times faster than the S&P 500, it can currently be purchased at a PE ratio of 12.2 which is less than you can buy the average company for. In other words, whether or not the stock market in general is cheap, I for one will certainly argue that Oracle definitely is.

[ Enlarge Image ]

Brown – Forman (BF.B)

In contrast to Oracle Corp., we discover that Brown-Forman with a significantly lower earnings growth rate is currently trading at one of its highest valuations ever. When you consider that this company trades ! at a PE r! atio of 23.3 versus the S&P 500 at a PE ratio of 13.7 or against Oracle with a PE ratio of only 12.1, we can see a wide variation in stock valuations of individual stocks as compared to the S&P 500 index.

[ Enlarge Image ]

The major point that I am attempting to make with the above portion of this article is that I believe focusing on generalities like the S&P 500's valuation is less relevant ( and even misleading) than looking at individual companies instead. In other words, unless you are investing in the index, I believe it always makes more sense to focus on what you actually own and their relative valuations.

Optimism The More Rational Perspective

Based on extensive research that I have conducted, and research that I am continuing to carry out, I believe the case for optimism regarding the future of the economies of our country, and even the world, is more persuasive than a negative view. Nevertheless, there continues to be a pervasive and prolific amount of negative press and articles suggesting that our economy is going to hell in a hand basket. And even worse, is the arrogant and even sanctimonious conviction where many writers present their opinion as fact. In other words, I can tolerate someone expressing their opinion, but I cannot tolerate expressing something you cannot possibly know as fact.

For example, I will paraphrase a comment that I recently read that illustrates my point. An author wrote an article expressing his view that economic growth in the future will be below trend and he followed this statement with the following words in parenthesis (which it almost certainly will be) followed by words to the effect that earnings growth will almost certainly be below trend. An underlying theme of this article is that neither he, nor I, nor anyone else can say with certainty what our future economic growth will be. The best that we can expect to do is to asse! ss the fa! cts and assign the most reasonable range of probabilities we can logically estimate. When I do this, I see a preponderance of evidence suggesting that our future sits on the threshold of the greatest growth ever witnessed in the history of humanity.

Most importantly, I base my optimistic view on looking to the future. By doing this, the evidence becomes very clear, technological advancements are improving our lives and economic opportunities at a mind-numbing and accelerating rate. However, far too many of us remain traumatized, and therefore, negative. Although the vast majority of us have a mountain of positive aspects in our lives and economic well-being to focus on, and perhaps only a thimble full of negative aspects, we tend to obsess with the negative while ignoring the positive. This may be the greatest risk of all that we face.

In the current New York Times best-selling book, Abundance the Future is Better Than You Think the authors Peter H. Diamandis and Steven Kotler put it in these words as they close Chapter 2 of their book:

"but first it's helpful to understand a little more about the roots of this cynicism, and why it's this reaction -- the inability of people to see the positive trends through the sea of bad news -- that may be the biggest stumbling block on the road toward abundance."

In other words, the above authors, like me, believe that perhaps the biggest risk we face is our attitude about the future. However, even our attitudes cannot stop the unbelievable potential in front of us. Unfortunately, most economic theory is based on what many call the scarcity principle. Under this theory, people constantly worry about dividing our economic pie into enough slices for everyone. However, what we are ignoring is that for the first time in history we will very soon no longer need to figure out how to divide our current pie, but instead we are learning how to bake an almost infinite number of more pies. Once we accomplish this, then abundance for all is ! certainly! within our grasp.

Summary and Conclusion

I fully acknowledge that there are numerous economic challenges and problems facing us. And furthermore, I acknowledge that some of these problems are significant enough to frighten or even overwhelm us. However, I also believe that we should never underestimate the indomitable human spirit and its enthusiasm, willingness and capability of solving even our most serious problems.

In the book Abundance referenced above, the authors discuss current and future advancements that portend to solve most of the challenges facing the world. These would include energy, education, healthcare, water scarcity and much more. The solutions they are writing about are available today or will be available within the next decade or two. In other words, most of what they are talking about already is available or will be in the very near future.

As I come to the end of this article I would like to share two of my all-time favorite quotes, one by American anthropologist Margaret Mead and the other from the 1997 Apple Computer advertising campaign Think Different, that were also included in the book Abundance:

"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has." Margaret Mead

And from Apple's Think Different advertising campaign:

"Think Different-here's to the crazy ones, the misfits, the rebels, the troublemakers, the round pegs in square holes… the ones who see things differently--- they're not fond of rules… you can quote them, disagree with them, glorify or vilify them, but the only thing you can't do is ignore them because they change things… they push the human race forward, and while some may see them as the crazy ones, we see genius, because the ones who are crazy enough to think that they can change the world are the ones who do."

With my final remarks on my belief in the validity of optimism, I would like to reference ano! ther book! that I believe is a must read written by Matt Ridley appropriately titled The Rational Optimist as follows:

"It will be hard to snuff out the flame of innovation, because it is such an evolutionary, bottom-up phenomenon in such a networked world. So long as human exchange and specialization are allowed to thrive somewhere, then culture evolves whether leaders help it or hinder it, and the result is that prosperity spreads, technology progresses, poverty declines, disease retreats, fecundity falls, happiness increases, violence atrophies, freedom grows, knowledge flourishes, the environment improves, and wilderness expands."

The bottom line point of this article is that the only way that it could be argued that stocks are not historically cheap today is to believe the pessimists who say that our future economy and corporate earnings are going to be weak. However, if you take an optimistic approach, as I do, then the only rational conclusion that can be made is that stocks are cheap today.

Disclosure: Long PEP, PG, JNJ and ORCL at the time of writing.

Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as predicted. The information in this document is believed to be accurate, but under no circumstances should a person act upon the information contained within. We do not recommend that anyone act upon any investment information without first consulting an investment adviser as to the suitability of such investments for his specific situation.

Thursday, January 16, 2014

Citigroup Inc Reports Higher Q4 Earnings, But Misses Estimates; Shares Fall (C)

Shares of financial services company Citigroup Inc (C) fell over 3% on Thursday morning after the company reported earnings that fell below analysts’ estimates.

Citi’s Earnings in Brief

Citi reported Q4 earnings of  $2.691 billion, or 85 cents per share, up from $1.196 billion, or 38 cents per share, last year. Excluding special items, earnings were 82 cents per share. Total revenue for the quarter dipped to $17.78 billion from $17.92 billion a year ago. Analysts estimated earnings of 95 cents per share on revenue of $18.18 billion.

CEO Commentary

Citi’s CEO Michael Corbat commented on the results: “Although we didn't finish the year as strongly as we would have liked, we made substantial progress toward our key priorities in 2013. Having grown our operating net income by 15% over 2012, we achieved our highest amount of net income since before the financial crisis. We accelerated our growth in capital and ended the fourth quarter with an estimated Basel III Tier 1 Common ratio of 10.5%, exceeding our target for the year. We also grew loans in our core businesses by 7%, utilized $2.4 billion of our deferred tax assets, and reduced the assets in Citi Holdings by 25% while cutting its annual loss in half. In addition, we improved our efficiency by executing on the repositioning actions announced at the end of 2012, reducing expenses and growing revenues. We enter 2014 as a strong and stable institution that is committed to achieving our 2015 financial targets and our objective of returning capital to our shareholders."

Citi’s Dividend

The company declared its next quarterly dividend of 1 cent per share. This dividend will be paid on February 28 to shareholders of record on February 3.  The stock will go ex-dividend on January 30.

Stock Performance 

Citigroup shares were down $1.72, or 3.11%, during pre-market trading Thursday.

AECOM Wins Mali Transition Contract - Analyst Blog

Leading provider of professional technical and management support services for public and private clients AECOM Technology Corporation (ACM) was recently awarded a $49 million contract by the U.S. Agency for International Development's Office of Transition Initiatives (USAID/OTI) for the Mali Transition Initiative (MTI). The MTI program aims to promote peace and stability in Mali, West Africa.

AECOM will be acting as the implementing partner for the three-year MTI program. As per the agreement, AECOM is expected to assist the U.S. government in reinstating democracy in Mali and making information freely available to the public.

The MTI program will also focus on providing immediate stability in Northern Mali with the re-establishment of the region's governance structures.

The contract will be included in the Management Support Services (MSS) segment of AECOM, which primarily offers program and facilities management and maintenance, training, logistics, consulting, technical assistance and systems integration services for the U.S. government. The MSS segment contributed $0.9 million or 11% of total consolidated revenue during fiscal 2012.

Based in Los Angeles, California, AECOM provides services to diversified markets such as transportation, facilities, environmental, energy and government. The company has around 45,000 employees to serve its clients, which are spread in more than 140 countries. AECOM reported revenues of $1.9 billion during its last quarter.

AECOM currently carries a Zacks Rank #3 (Hold). Some better-placed stocks in the construction sector that are worth a look include DR Horton Inc. (DHI), Dycom Industries Inc. (DY) and Eagle Materials Inc. (EXP). All these stocks carry a Zacks Rank #1 (Strong Buy).

Wednesday, January 15, 2014

New High for the S&P 500…Barely; Deflation a Threat?

After spending the first two weeks of January in the red, the S&P 500 pushed into record territory by a nose as Apple (AAPL), Microsoft (MSFT), General Electric (GE) and JPMorgan (JPM) helped drive the benchmark higher.

Associated Press

The S&P 500 gained 0.5% to 1,848.38 today–a new all-time high by just 0.02 points– while the Dow Jones Industrial Average rose 108.08 points, or 0.7%, to 16,481.94, although the blue-chip index is still down 0.6% this year. The small-cap Russell 2000 advanced 0.7% to 1,170.95 and is now up 0.6% in 2014.

The S&P 500′s bigger stocks did the heavy lifting today. Apple jumped 2% to $557.36 today after its CEO made positive comments about the company’s deal to sell the iPhone with China Mobile (CHL), while Microsoft rose 2.5% to $48.27, and General Electric advanced 1.4% to $27.34. Bank of America (BAC) finished up 2.3% at $17.15 after beating earnings forecasts, while JPMorgan gained 3% to $59.49 in a delayed reaction to its own earnings release yesterday.

Today, stocks were given a boost by two pieces of economic data. The Empire State Manufacturing index, a gauge of industrial activity in the New York region, rose to 12.5, the highest since 2012. The so-called core producer-price index rose 0.3% in December, the largest increase since 2012.

Jefferies’ Thomas Simons calls the manufacturing data “encouraging.” He writes:

Manufacturing PMIs, Fed surveys, and other sentiment indexes have recently shown evidence that the sector is gaining traction, but strength is mixed across the various regions.  This is the first regional report for the month of January so it is encouraging to see a high level of optimism heading into the New Year.  The Empire survey has set the tone for a strong month of manufacturing indexes.

Newedges’ Annalisa Piazza explains that investors shouldn’t fret about inflation. She writes:

Despite today’s higher-than-expected PPI print, we rule out the Fed will change its assessment on inflation at its next FOMC meeting in late January. Inflationary pressures remains well subdued and the Fed looks beyond the short-term volatility, judging the stability of inflation expectations as a favourable factor for a gradual reduction of the current QE programme.

Societe General’s Albert Edwards ponders why markets refuse to acknowledge the risk of deflation. He writes:

Markets remain stoic about the risks of outright deflation in the US and eurozone for one very simple reason – they simply do not believe a recession that would trigger outright deflation is on the horizon. Quite the reverse – they believe with all their heart that we are at the start of a self-sustained recovery. That is despite the fact that the US recovery is already noticeably longer than average, and that the classic signs of old age, such as rapidly slowing productivity growth and stagnant corporate profits, can clearly be seen…

And however much US and eurozone policy makers deny we are witnessing a repeat of what happened in Japan in the 1990s, it does indeed look just like Japan to me.

I can guarantee–almost no one is thinking about that right now.

Swedish Researchers Raise Infant Safety Concerns About J & J's Tylenol

Tylenol, Johnson & Johnson's big selling painkiller, is in the news today after Swedish researchers raised questions about its active ingredient, paracetamol. The researchers, based at Uppsala University, found that paracetamol can cause long-lasting cognitive effects in young mice, including decreased learning and memory capabilities.

Paracetamol is the key ingredient also in Panadol, a similar painkiller widely marketed in the U.K. and many other parts of the world. Panadol is made by London-based GlaxoSmithKline. (Disclosure: I own stock in GlaxoSmithKline.)

The study was conducted by Henrik Viberg and three others, and was published in Toxicological Sciences, the journal of the Reston, Virginia-based Society of Toxicology.

An abstract of the study can be read here.

The researchers were reported yesterday as urging that parents should be careful in administering the drug.

As quoted in the Upsala Nya Tidning newspaper,  Henrik Viberg commented: "This shows that there are reasons to restrict the use of paracetamol late in pregnancy and to hold back from giving the medicine to infants."

Monday, January 13, 2014

Three Small Cap Stocks Acting Like the Titanic: FBEC, ICBU & DMHI

Small cap stocks Frontier Beverage Company Inc (OTCMKTS: FBEC), IMD Companies Inc (OTCMKTS: ICBU) and Dmh International Incorporated (OTCBB: DMHI) were all mimicking the Titanic last Friday by sinking 41.18%, 32.5% and 28.16%, respectively, last Friday. Moreover, all three of these stocks have been the subject of paid promotions or investor relation campaigns. With the promotions in mind, is it to late to dump these small cap stocks or will this week present a buying opportunity? Here is a closer look:

Frontier Beverage Company Inc (OTCMKTS: FBEC) Announces Changes and Proposed Plans

Small cap Frontier Beverage Company is a diversified holding company with the following subsidiaries: 22 Social Club Productions, Blue 22 Entertainment and App Quest LLC. On Friday, Frontier Beverage Company sank 41.18% to $0.005 for a market cap of $93,905 plus FBEC is down 77.5% since last March and down 99.2% over the past five years according to Google Finance.

z?s=FBEC&t=5d&q=l&l=on&z=l&a=v&p=s&lang=

What's the Catch With Frontier Beverage Company? According to various disclosures, transactions of $5k and $22.5k have or will occur to mention Frontier Beverage Company in various investment newsletters. Last Wednesday, Frontier Beverage Company announced new changes and proposed plans for 2014. The changes or plans included plans to expand into the Dance/Electronic, Rock and Country genres (which will include revenue streams such as live event and festival productions, artist signings as well as film and music production and distribution); exploring funding a majority of projects though direct event investment with the goal of movement to the AMEX exchange; and a cost cutting move involving the ceasing of operations for APPQUEST and the Beverage Division as the company will seek an outsourcing strategy rather than an in-house strategy in order to focus more on the growth of the core business Media & Entertainment. In addition, Frontier Beverage Company has come to an agreement with Gallant Acquisitions Corp to sell 30% or 72,000,000 of 22 Social Club Productions common stock for the return of 100 million shares of Frontier Beverage Company common stock that will reduce the issued and outstanding of the common shares of the company. Otherwise, Frontier Beverage Company announced back in December that it had signed a Joint Venture Agreement with Starzz Live for the formation of a Live Event Production Company for the production of live events in the Southern United States with the new entity to launch this month. A quick look at Frontier Beverage Company's financials reveals no revenues; net losses of $27k (most recent reported quarter), $21k and $33k and net income of $38k for the past four quarters; and no cash to cover $520k in current liabilities at the end of September. So perhaps investors should wait for more up to date financials to appear.

IMD Companies Inc (OTCMKTS: ICBU) Aims for a High on Marijuana

Small cap IMD Companies Inc is involved in the medical diagnostics and health and fitness industries plus the company has announced it intends to become a player in the Medical Marijuana sector. On Friday, IMD Companies Inc sank 32.5% to $0.0270 for a market cap of $1.66 million plus ICBU is up 35% over the past year and up 575% over the past five years according to Google Finance.

z?s=ICBU&t=5y&q=l&l=on&z=l&a=v&p=s&lang=

What's the Catch With IMD Companies Inc? According to various disclosures, a transaction or transactions of $15k has or will occur to IMD Companies Inc in various investment newsletters plus one promoter expects to be compensated to perform investor relations services for ICBU at some time in the future. Last Thursday, IMD Companies Inc announced it had formed a partnership with Anything Technologies Media Inc, (OTCMKTS: EXMT) by acquiring a 51% interest in R-Quest Hydroponics, Inc, the developer of the environmental master controller for medical and recreational marijuana hydroponic gardens. IMD Companies Inc paid 100 million common restricted shares to Anything Technologies Media Inc who will continue to manufacture the EMC-5000 system as part of the partnership. The press release noted:


"This is the first of many acquisitions and partnerships that the Company plans to make in the fast-growing medical, recreational marijuana sector. IMD is currently in negotiations with several other partnership and acquisition candidates in the supply and service industry for the marijuana sector. The company plans on making several announcements within the next 30 days as agreements are finalized."

A quick look at Google Finance for IMD Companies Inc's financials reveals revenues of $0.13M (most recent reported quarter), $0.10M, $0.11M and $0.11M for the past four reported quarters and net losses of $0.24M (most recent reported quarter), $0.06M, $0.04M and $0.10M. At the end of June, IMD Companies Inc had no cash to cover $0.11M in current liabilities and long term debt of $1.01M. So no marijuana highs yet for the company or for investors.

Dmh International Incorporated (OTCBB: DMHI) Prepares for an Acquisition

Small cap Dmh International Incorporated through its subsidiary, Touch Medical Solutions, is a medical software and device company specializing in PACS (Picture Archiving and Communications Systems), EHR (Electronic Hospital records), EMR (Electronic Medical Records), PHR (Personal Health Records), Medical Transcription, and Paperless Medical Office Solutions. On Friday, Dmh International Incorporated sank 28.16% to $0.0199 for a market cap of $4.23 million plus DMHI is down 60.2% over the past year or so according to Google Finance.

z?s=DMHI&t=1y&q=l&l=on&z=l&a=v&p=s&lang=

What's the Catch With Dmh International Incorporated? According to various disclosures, a transaction or transactions of $15k has or will occur to mention Dmh International Incorporated in various investment newsletters. Last Thursday, Dmh International Incorporated announced the launch of their FDA approved Touch PACS software for sale in Q1 of 2014 in anticipation of the completion of their announced merger with the Virtual Physician's Network (VPN) - a mobile healthcare business applications company offering the first fully integrated virtual event and professional networking platform combined with proprietary practice building tools for surgeons, healthcare professionals and medical vendors. In addition and on Wednesday, Dmh International Incorporated announced the expansion of its Advisory Board in anticipation of the merger while the last update about the merger came on December 12 when it was noted:


"Virtual Physician's Network's products are a great addition to our medical imaging and medical records software. They bring entirely new applications and markets to the company as well as seasoned management, software designers and sales support that has been lacking at DMH International."

A quick look at Dmh International Incorporated's financials reveals no revenues; net losses of $184k (most recent reported quarter), $380k, $146k and $152k for the past four reported quarters; and had $3k in cash to cover $928k in accounts payable at the end of September. Given Dmh International Incorporated's ongoing acquisition and financials, investors should wait for more financials to appear.

Sunday, January 12, 2014

Will Arena Pharmaceuticals See Rising Prices?

With shares of Arena Pharmaceuticals (NASDAQ:ARNA) trading around $8, is ARNA an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let's analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing drugs. Its primary focus is on four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. The company’s main product is Belviq, a drug approved by the United States food and drug administration for chronic weight management in adults. Arena Pharmaceuticals is also involved in the development of drugs for the treatment of pulmonary arterial hypertension, thrombotic diseases, autoimmune diseases, pain, and type 2 diabetes. Look for Arena Pharmaceuticals to continue to make progress in their respective research areas and revolutionize treatments of illness and diseases that cause distress among consumers worldwide.

T = Technicals on the Stock Chart are Mixed

Arena Pharmaceuticals stock has seen a downtrend over the last few years. However, the stock saw a powerful run just last year and is currently consolidating the gains from this move. Analyzing the price trend and its strength can be done using key simple moving averages. What are the key moving averages? The 50-day (pink), 100-day (blue), and 200-day (yellow) simple moving averages. As seen in the daily price chart below, Arena Pharmaceuticals is trading around its key averages which signal neutral price action in the near-term.

ARNA

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

(Source: Thinkorswim)

Taking a look at the implied volatility (red) and implied volatility skew levels of Arena Pharmaceuticals options may help determine if investors are bullish, neutral, or bearish.

Implied Volatility (IV)

30-Day IV Percentile

90-Day IV Percentile

Arena Pharmaceuticals Options

74.33%

70%

68%

What does this mean? This means that investors or traders are buying a very significant amount of call and put options contracts, as compared to the last 30 and 90 trading days.

Put IV Skew

Call IV Skew

June Options

Steep

Average

July Options

Steep

Average

As of today, there is an average demand from call buyers or sellers and high demand by put buyers or low demand by put sellers, all neutral to bearish over the next two months. To summarize, investors are buying a very significant amount of call and put option contracts and are leaning neutral to bearish over the next two months.

On the next page, let’s take a look at the earnings and revenue growth rates and the conclusion.

E = Earnings Are Improving Quarter-Over-Quarter

Rising stock prices are often strongly correlated with rising earnings and revenue growth rates. Also, the last four quarterly earnings announcement reactions help gauge investor sentiment on Arena Pharmaceuticals’s stock. What do the last four quarterly earnings and revenue growth (Y-O-Y) figures for Arena Pharmaceuticals look like and more importantly, how did the markets like these numbers?

2013 Q1

2012 Q4

2012 Q3

2012 Q2

Earnings Growth (Y-O-Y)

50%

39.61%

56.25%

25%

Revenue Growth (Y-O-Y)

8.41%

-6.74%

-57.07%

574.3%

Earnings Reaction

-0.12%

-1.79%

-4.73%

-1.22%

Arena Pharmaceuticals has seen improving earnings and mixed revenue figures over the last four quarters. From these numbers, the markets have been fairly disappointed with Arena Pharmaceuticals’s recent earnings announcements.

P = Poor Relative Performance Versus Peers and Sector

How has Arena Pharmaceuticals stock done relative to its peers, GlaxoSmithKline (NYSE:GSK), Biomarin Pharmaceutical (NASDAQ:BMRN), NuPathe (NASDAQ:PATH), and sector?

Arena Pharmaceuticals

GlaxoSmithKline

Biomarin Pharmaceutical

NuPathe

Sector

Year-to-Date Return

-3.22%

20.06%

17.66%

-8.28%

20.31%

Arena Pharmaceuticals has been a poor relative performer, year-to-date.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

Conclusion

Arena Pharmaceuticals is involved in the research and development of valuable pharmaceuticals that may help consumers live better lives. The stock saw a powerful move just last year and is still in the process of digesting its gains. Over the last four quarters, earnings have been improving while revenue figures have been mixed, which has disappointed investors in the stock. Relative to its peers and sector, Arena Pharmaceuticals has been a poor year-to-date performer. WAIT AND SEE what Arena Pharmaceuticals does in coming quarters.

Why Harley-Davidson Is On the Move

Harley-Davidson's (NYSE: HOG  ) profit engine is revving up. Despite a cold and wet spring in the U.S., the motorcycle maker saw its earnings bounce in the second quarter of 2013.

Profits rose by 13% to $1.21 a share, versus the $1.08 that Harley managed in the year-ago quarter.

The company didn't get much help from the weather this time around. What Harley described as a "prolonged and unseasonably cool and wet spring" put the brakes on sales in the U.S., which logged just a 4.4% rise in motorcycle sales. Harley also had a tough comparison to deal with. Last year's spring was "abnormally early and warm" in North America, the company pointed out.

Still, cost cuts and strong global results more than picked up the slack from uncooperative weather patterns. Worldwide sales came in at 90,000 motorcycles, well ahead of the 80,000 to 85,000 that the company had forecast for the quarter.

Gross margin also came in much better than expected. Harley managed to boost that figure by a full percentage point, to 36.9%. The company is still reaping big benefits from its transition into a leaner production model. One example of that move is the surge production at its York, Pa., plant. The aim there was to increase flexibility by moving production closer to the prime shopping season. Harley says the new strategy has been a "great success," and that's evident in the company's rising profitability since launching it.

Quarter

2012 Gross Margin

2013 Gross Margin

Q1 

35.9%

36.7%

Q2 

35.9%

36.9%

Source: Company financial filings.

That weakness in the North American market might have kept a cap on the company's sales expectations for the full year. Despite this quarter's beat, Harley didn't change its forecast for between 259,000 and 264,000 total motorcycle shipments in 2013, or 5% better than last year's haul. But a more efficient operation means that investors can expect earnings to grow much faster than that. In fact, profits are already tracking 21% higher through the first six months of this year.

Are you looking for international exposure in your portfolio? China is already the world's largest auto market -- and it's set to grow even bigger in coming years. A recent Motley Fool report, "2 Automakers to Buy for a Surging Chinese Market," names two global giants poised to reap big gains that could drive big rewards for investors. You can read this report right now for free -- just click here for instant access.